WIMAN LAB
Selected publications

Publications

Selected publications

Representative papers spanning basic mechanistic studies and translational development of p53-targeting strategies.
2018

Cell Chemical Biology

p53 as a hub in cellular redox regulation and therapeutic target in cancer

2009

Cancer Cell

PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain (Lambert et al.)

2013

PNAS

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase

2017

Nature Communications

Human cancer-associated fibroblasts enhance glutathione levels and antagonise drug-induced prostate cancer cell death

2022

Cell Death & Disease

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5‑Fluorouridine

2020

Cell Death Discovery

A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumour cell death

2024

Nature Reviews Clinical Oncology

Therapeutic targeting of TP53 nonsense mutations in cancer

2007

PNAS

The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element